Skip to main content

Advertisement

Log in

Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015–2016

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Previous reports suggest that adults with inflammatory bowel disease (IBD) receive suboptimal preventive care.

Aims

The population-based study compared the receipt of these services by US adults with and without IBD.

Methods

Adults aged ≥ 18 years with IBD (1.2%) and without IBD were identified from the 2015 and 2016 National Health Interview Survey (n = 66,610). Age-standardized prevalence of doctor visits, receipt of medical advice, and selected preventive care was calculated for adults with and without IBD. The model-adjusted prevalence ratios were estimated for receipt of preventive care associated with IBD.

Results

The prevalence of a doctor visit in the past 12 months was significantly higher among adults with IBD than those without. IBD was also associated with significantly higher prevalence of receiving medical advice about smoking cessation (83.9% vs. 66.4%) and diet (42.9% vs. 32.1%), having colon cancer screening in the past 12 months (44.0% vs. 26.7%), having ever had an HIV test (51.5% vs. 45.4%) or pneumococcal vaccine (75.3% vs. 64.0%), having received a tetanus vaccine in the past 10 years (72.0% vs. 61.8%), and having received a flu vaccine in the past 12 months (48.4% vs. 41.0%), but was not significantly associated with receiving cervical cancer screening and hepatitis A and B vaccines.

Conclusions

Adults with IBD were more likely to receive many types of preventive care than adults without IBD. The findings can inform healthcare policy makers to make strategic decisions that enhance multidisciplinary coordination from various medical specialties to ensure optimal preventive care for IBD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Xu F, Dahlhamer JM, Zammitti EP, Wheaton AG, Croft JB. Health-risk behaviors and chronic conditions among adults with inflammatory bowel disease—United States, 2015 and 2016. MMWR Morb Mortal Wkly Rep. 2018;67:190–195. https://doi.org/10.15585/mmwr.mm6706a4.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn’s Colitis. 2007;1:10–20. https://doi.org/10.1016/j.crohns.2007.06.005.

    Article  Google Scholar 

  3. Roman AL, Munoz F. Comorbidity in inflammatory bowel disease. World J Gastroenterol. 2011;17:2723–2731. https://doi.org/10.3748/wjg.v17.i22.2723.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:47–52.

    Article  PubMed  Google Scholar 

  5. Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Reps. 2008;10:597–605.

    Article  Google Scholar 

  6. Murthy SK, Nguyen GC. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol. 2011;106:713–718.

    Article  PubMed  Google Scholar 

  7. Filimon AM, Negreanu L, Doca M, Ciobanu A, Preda CM, Vinereanu D. Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons. World J Gastroenterol. 2015;21:9688–9692. https://doi.org/10.3748/wjg.v21.i33.9688.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chang M, Chang L, Chang HM, Chang F. Intestinal and extraintestinal cancers associated with inflammatory bowel disease. Clin Colorectal Cancer. 2018;17:e29–e37. https://doi.org/10.1016/j.clcc.2017.06.009.

    Article  PubMed  Google Scholar 

  9. Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn Colitis. 2014;8:443–468. https://doi.org/10.1016/j.crohns.2013.12.013.

    Article  CAS  Google Scholar 

  10. Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol. 2016;22:7625–7644. https://doi.org/10.3748/wjg.v22.i34.7625.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kremers HM, Bidaut-Russell M, Scott CG, Reinalda MS, Zinsmeister AR, Gabriel SE. Preventive medical services among patients with rheumatoid arthritis. J Rheumatol. 2003;30:1940–1947.

    PubMed  Google Scholar 

  12. Owens MD, Beckles GL, Ho KK, Gorrell P, Brady J, Kaftarian JS. Women with diagnosed diabetes across the life stages: underuse of recommended preventive care services. J Women Health (Larchmt). 2008;17:1415–1423. https://doi.org/10.1016/10.1089/jwh.2008.1125.

    Article  Google Scholar 

  13. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Ggastroenterol. 2017;112:241–258. https://doi.org/10.1038/ajg.2016.537.

    Article  Google Scholar 

  14. Selby L, Hoellein A, Wilson JF. Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients? Dig Dis Sci. 2011;56:819–824. https://doi.org/10.1007/s10620-010-1329-8.

    Article  PubMed  Google Scholar 

  15. National Center for Health Statistics. Survey Description, National Health Interview Survey. 2015. Hyattsville, Maryland. 2016. Avaiable at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2015/srvydesc.pdf. Accessed July 13, 2018.

  16. National Center for Health Statistics. Survey Description, National Health Interview Survey. 2016. Hyattsville, Maryland. 2017. Avaiable at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2016/srvydesc.pdf. Accessed July 13, 2018.

  17. U.S. Preventive Service Task Force. U.S. Preventive Service Task Force published recommendations. 2017. https://www.uspreventiveservicestaskforce.org/BrowseRec/Index. Accessed February 27, 2018.

  18. Bieler GS, Brown GG, Williams RL, Brogan DJ. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010;171:618–623. https://doi.org/10.1093/aje/kwp440.

    Article  PubMed  Google Scholar 

  19. National Center for Health Statistics. National Center for Health Statistics data presentation standards for proportions. 2017; Available from https://www.cdc.gov/nchs/data/series/sr_02/sr02_175.pdf. Accessed Feburary 23, 2018.

  20. Selby L, Kane S, Wilson J, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008;14:253–258. https://doi.org/10.1002/ibd.20266.

    Article  PubMed  Google Scholar 

  21. Kappelman MD, Porter CQ, Galanko JA, et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:62–68. https://doi.org/10.1002/ibd.21371.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mady R, Grover W, Butrus S. Ocular complications of inflammatory bowel disease. ScientificWorldJournal. 2015;2015:438402. https://doi.org/10.1155/2015/438402.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Severs M, Mangen MJ, van der Valk ME, et al. Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease. J Crohn’s Colitis. 2017;11:342–352. https://doi.org/10.1093/ecco-jcc/jjw160.

    Article  CAS  Google Scholar 

  24. Crohn’s & Colitis Foundation. Nutrition, diet, and inflammatory bowel disease. 2013; Available from: http://www.crohnscolitisfoundation.org/resources/diet-nutrition-ibd-2013.pdf. Accessed October 25, 2018.

  25. Halmos EP, Gibson PR. Dietary management of IBD–insights and advice. Nat Rev. Gastroenterol Hepatol. 2015;12:133–146. https://doi.org/10.1038/nrgastro.2015.11.

    Article  CAS  PubMed  Google Scholar 

  26. Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016;22:4794–4801. https://doi.org/10.3748/wjg.v22.i20.4794.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Waszczuk E, Waszczuk K, Bohdanowicz-Pawlak A, Florjanski J. Women with inflammatory bowel diseases have a suboptimal cervical cancer screening rate and are not aware of the recommended human papilloma virus vaccine. Gynecol endocrinol. 2018;34:656–658. https://doi.org/10.1080/09513590.2017.1416466.

    Article  PubMed  Google Scholar 

  28. Centers for Disease Control and Prevention. The Advisory Committee on Immunization Practices. 2018; Avaiable at: https://www.cdc.gov/vaccines/acip/index.html. Accessed July 16, 2018.

  29. Gurvits GE, Lan G, Tan A, Weissman A. Vaccination practices in patients with inflammatory bowel disease among general internal medicine physicians in the USA. Postgrad Med J. 2017;93:333–337. https://doi.org/10.1136/postgradmedj-2016-134266.

    Article  PubMed  Google Scholar 

  30. Wasan SK, Calderwood AH, Long MD, Kappelman MD, Sandler RS, Farraye FA. Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis. 2014;20:246–250. https://doi.org/10.1097/01.mib.0000437737.68841.87.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Malhi G, Rumman A, Thanabalan R, et al. Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. J Crohn’s Colitis. 2015;9:439–444. https://doi.org/10.1093/ecco-jcc/jjv064.

    Article  Google Scholar 

Download references

Acknowledgments

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Author information

Authors and Affiliations

Authors

Contributions

FX drafted the paper. JMD and EPT conducted data analyses. FX, JMD, EPT, AGW, and JBC participated in the study design, interpreted the results, reviewed and edited the paper, and approved the final version.

Corresponding author

Correspondence to Fang Xu.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, F., Dahlhamer, J.M., Terlizzi, E.P. et al. Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015–2016. Dig Dis Sci 64, 1798–1808 (2019). https://doi.org/10.1007/s10620-019-05494-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-019-05494-w

Keywords

Navigation